Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Limongelli

Showing results (461-470 of 485) with videos related to

Pageof 49
Sort By:
ESC Heart Failure|January 2, 2020
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fractionElisabetta Salvioni, Ugo Corrà, Massimo Piepoli, et al.
Circulation|January 5, 2026
Clinical Spectrum of Children With Parvovirus B19-Associated Acute MyocarditisEnrico Ammirati, Giacomo Veronese, Francesca Raimondi, et al.
European Journal of Preventive Cardiology|September 9, 2021
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE StudyMarco Merlo, Aldostefano Porcari, Linda Pagura, et al.
European Journal of Heart Failure|September 27, 2017
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparisonPiergiuseppe Agostoni, Stefania Paolillo, Massimo Mapelli, et al.
European Journal of Heart Failure|February 25, 2017
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score databaseStefania Paolillo, Massimo Mapelli, Alice Bonomi, et al.
European Journal of Heart Failure|April 13, 2022
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide surveyMarco Merlo, Linda Pagura, Aldostefano Porcari, et al.
ESC Heart Failure|September 20, 2024
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND studyGiacomo Tini, Beatrice Musumeci, Paolo Milani, et al.
European Journal of Internal Medicine|October 4, 2016
Heart failure and anemia: Effects on prognostic variablesGaia Cattadori, Piergiuseppe Agostoni, Ugo Corrà, et al.
European Journal of Heart Failure|March 12, 2023
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network studyGiacomo Tini, Paolo Milani, Mattia Zampieri, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 17, 2026
Acute coronary syndrome and coronary artery disease in wild-type transthyretin amyloid cardiomyopathy: a DIAMOND sub-studyLaura De Michieli, Giacomo Tini, Alessia Argirò, et al.
Pageof 49

Showing results (461-470 of 485) with videos related to

Sort By:
Pageof 49
ESC Heart Failure|January 2, 2020
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fractionElisabetta Salvioni, Ugo Corrà, Massimo Piepoli, et al.
Circulation|January 5, 2026
Clinical Spectrum of Children With Parvovirus B19-Associated Acute MyocarditisEnrico Ammirati, Giacomo Veronese, Francesca Raimondi, et al.
European Journal of Preventive Cardiology|September 9, 2021
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE StudyMarco Merlo, Aldostefano Porcari, Linda Pagura, et al.
European Journal of Heart Failure|September 27, 2017
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparisonPiergiuseppe Agostoni, Stefania Paolillo, Massimo Mapelli, et al.
European Journal of Heart Failure|February 25, 2017
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score databaseStefania Paolillo, Massimo Mapelli, Alice Bonomi, et al.
European Journal of Heart Failure|April 13, 2022
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide surveyMarco Merlo, Linda Pagura, Aldostefano Porcari, et al.
ESC Heart Failure|September 20, 2024
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND studyGiacomo Tini, Beatrice Musumeci, Paolo Milani, et al.
European Journal of Internal Medicine|October 4, 2016
Heart failure and anemia: Effects on prognostic variablesGaia Cattadori, Piergiuseppe Agostoni, Ugo Corrà, et al.
European Journal of Heart Failure|March 12, 2023
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network studyGiacomo Tini, Paolo Milani, Mattia Zampieri, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 17, 2026
Acute coronary syndrome and coronary artery disease in wild-type transthyretin amyloid cardiomyopathy: a DIAMOND sub-studyLaura De Michieli, Giacomo Tini, Alessia Argirò, et al.
Pageof 49